Tenor Capital Management’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Tenor Capital Management’s Portfolio LVACW Stock Details LVACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-125,000	Closed	-$9.38K	–	486
2023 Q1	$9.38K	Hold	125,000	–	–	﹤0.01%	353
2022 Q4	$638	Hold	125,000	–	–	﹤0.01%	606
2022 Q3	$10K	Hold	125,000	–	–	﹤0.01%	593
2022 Q2	$14K	Hold	125,000	–	–	﹤0.01%	644
2022 Q1	$44K	Buy	+125,000	New	+$50.6K	﹤0.01%	606

Tenor Capital Management's LVACW Position: Q2 2023 in Review

Tenor Capital Management sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q2 2023, closing a stake of 125,000 shares — an estimated $9.38K sold.

Tenor Capital Management first reported a position in LVACW in Q1 2022 and held it in 5 quarters. The position peaked at $44K in Q1 2022. 0 funds tracked by Wall St. Rank hold LVACW as of Q2 2023.

Tenor Capital Management reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
Tenor Capital Management sold 125,000 LAVA Medtech Acquisition Corp. Warrants shares in Q2 2023, an estimated $9.38K.
Tenor Capital Management first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q1 2022 and held it in 5 quarters.
Tenor Capital Management's LAVA Medtech Acquisition Corp. Warrants position peaked at $44K in Q1 2022.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q2 2023.

Based on Tenor Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.